[September 02, 2014]

Research and Markets: Generic and Innovative Drugs Market in CIS Countries 2014: Russia, Ukraine and Kazakhstan Development Forecasts for 2014-2019

Research and Markets (http://www.researchandmarkets.com/research/kmmhjv/generic_and) has announced the addition of the "Generic and Innovative Drugs Market in CIS Countries 2014: Russia, Ukraine and Kazakhstan Development Forecasts for 2014-2019" report to their offering.

The report includes detailed profiles of the leading manufacturers of these medicines throughout the CIS region that name best-selling products in addition to supplying financial data. It provides input from physicians and patients on the generic and innovative drugs available, including their opinions about purchase and use of these specific types of treatments.

The report is very effective at clarifying regulatory conditions and processes utilised in the generic an innovative drug segments in each country. It examines current reimbursement procedures; pricing regulations and drug mark up rates, patent expiry and data exclusivity periods for medicines in each market. It enables quick and simple comparative analysis of generic and innovative drugs market conditions across Russia, Ukraine and Kazakhstan - compiled to meet the information needs of a variety of professionals.

This report is vital to the operations of generic and innovative drug manufacturers, potential participants evaluating the markets and preparing for entry and banking, investment and brokerage specialists with interests in the CIS pharma markets. It is useful to government agencies, business consultants, analysts and researchers, as well as chambers of commerce and organizations tasked with promotion of trade and commerce in this sector.

Generic and innovative drugs market in CIS countries, Russia, Ukraine and Kazakhstan, development forecasts for 2014-2019 provides essential support when conducting a variety of tasks, including making adjustments to product portfolios, launching new business ventures, comparing the regulatory conditions in each country and estimating growth potential in the generic and innovative drug markets in each country through 2019.

Key Topics Covered:

1. Executive summary
2. Characteristics of generic and innovative drugs markets in CE countries - comparative analysis
3. Analysis of individual countries
4. Generic and innovative drugs
5. Pricing and reimbursement
6. Key manufacturers

For more information visit http://www.researchandmarkets.com/research/kmmhjv/generic_and

[ Back To TMCnet.com's Homepage ]